**Core Concept**
Alpha-1 antitrypsin (A1AT) deficiency is a genetic disorder characterized by reduced levels of the protease inhibitor A1AT, leading to lung and liver disease. A1AT is produced in the liver and secreted into the bloodstream, where it protects the lungs from the enzyme neutrophil elastase.

**Why the Correct Answer is Right**
Alpha-1 antitrypsin deficiency is indeed a deficiency of a protease inhibitor (Option A), as A1AT is the primary inhibitor of neutrophil elastase. This deficiency is inherited in an autosomal recessive pattern (Option B), meaning that an individual must inherit two copies of the mutated gene (one from each parent) to express the disease. Patients with A1AT deficiency may also present with cholestatic jaundice (Option C), a condition characterized by a reduction in bile flow, leading to a buildup of bilirubin in the blood.

**Why Each Wrong Option is Incorrect**
**Option A:** While A1AT is a protease inhibitor, stating that the deficiency is simply a "deficiency of protease inhibitor" is too vague, as there are many other protease inhibitors in the body. However, A1AT is the primary protease inhibitor in the lungs.
**Option B:** While A1AT deficiency is inherited in an autosomal recessive pattern, stating that it is "autosomal recessive" alone is incomplete, as it does not convey the primary defect in protease inhibition.
**Option C:** While cholestatic jaundice is a possible presentation of A1AT deficiency, it is not the only possible presentation, and stating that it "may cause" cholestatic jaundice underplays the complexity of the disease.

**Clinical Pearl / High-Yield Fact**
A1AT deficiency is often referred to as "congenital emphysema" because it can cause premature emphysema in young adults, even in the absence of smoking. This is a key point to remember, as A1AT deficiency can have significant clinical implications, even in patients without a history of smoking.

**Correct Answer Line**
✓ Correct Answer: D. All of the above